Articles in Knowledge Corner
Many injections, apart from being unnecessary, are also unsafe. These chronic infections lead to a high burden of morbidity and mortality. There are safe injections protocols available. Such protocols have been mandatory by accreditation organisations like ISO, NABH and JCI in India and abroad. Best practices are available across selection, preparation, administration and disposal of Injections.
Foetal cells are less immunogenic than adult cells, and amniotic fluid cells are even less immunogenic than foetal cells. Foetal care from the day one of conception to first few years after birth are very crucial in a child’s life to ensure higher immunogenicity for its future. So, when a baby is born with an in-born disease, is it due to changing lifestyle conditions of the mother when she is pregnant or is it a genetic disorder?
Since the first successful transplantation of umbilical cord blood it has become an important source of haematopoietic stem and progenitor cells for the treatment of blood and genetic disorders. Significant progress has been accompanied by challenges.
As an experienced clinician, surgeon, teacher and industry expert, Dr Robert Wah, Vice President and Chief Medical Officer, CSC’s North American Public Sector, is an influential member of the medical and technology community. Wah,is also responsible for developing strategy and leading and evangelising the CSC Healthcare point of view. He discusses the opportunities and benefits of EHR.
With the recent political changes and string of announcements set to change the healthcare scenario in Lucknow, in the near future it will be worth noticing how the city of nawabs and kababs will be rechristened as the city of healthcare and hospitals.
The clinical research industry has taken a huge leap in Indian healthcare. To ensure that patient safety is the prime focus for clinical trials, laws and regulations need to be streamlined and adhered to. Experts take on whether the Drug Controller General of India (DCGI) is doing a good job at regulating clinical trials in India?